These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26997152)

  • 21. Imaging of hypoxia using PET and MRI.
    Gaertner FC; Souvatzoglou M; Brix G; Beer AJ
    Curr Pharm Biotechnol; 2012 Mar; 13(4):552-70. PubMed ID: 22214501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced Contrast Agents for Multimodal Biomedical Imaging Based on Nanotechnology.
    Calle D; Ballesteros P; Cerdán S
    Methods Mol Biol; 2018; 1718():441-457. PubMed ID: 29341024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nano versus Molecular: Optical Imaging Approaches to Detect and Monitor Tumor Hypoxia.
    Cheng MHY; Mo Y; Zheng G
    Adv Healthc Mater; 2021 Jan; 10(2):e2001549. PubMed ID: 33241672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies.
    Bache M; Kappler M; Said HM; Staab A; Vordermark D
    Curr Med Chem; 2008; 15(4):322-38. PubMed ID: 18288988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography.
    Wijsman R; Kaanders JH; Oyen WJ; Bussink J
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):244-56. PubMed ID: 24045621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiolabelled probes targeting tumor hypoxia for personalized medicine.
    Mees G; Sathekge M; Maes A; Van de Wiele C
    Curr Pharm Des; 2014; 20(14):2308-18. PubMed ID: 24025104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging of Tumor Characteristics and Molecular Pathways With PET: Developments Over the Last Decade Toward Personalized Cancer Therapy.
    Marcu LG; Moghaddasi L; Bezak E
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1165-1182. PubMed ID: 29907486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography.
    Aboagye EO; Kelson AB; Tracy M; Workman P
    Anticancer Drug Des; 1998 Sep; 13(6):703-30. PubMed ID: 9755726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for Tumor Hypoxia Imaging Based on Aggregation-Induced Emission Fluorogens.
    Xue T; Shen J; Shao K; Wang W; Wu B; He Y
    Chemistry; 2020 Feb; 26(12):2521-2528. PubMed ID: 31692097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multifunctional nanotheranostic for the intelligent MRI diagnosis and synergistic treatment of hypoxic tumor.
    Song R; Zhang M; Liu Y; Cui Z; Zhang H; Tang Z; Chen X; Wu H; Yao Z; He M; Bu W
    Biomaterials; 2018 Aug; 175():123-133. PubMed ID: 29804000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in evaluation of primary brain tumors.
    Chen W; Silverman DH
    Semin Nucl Med; 2008 Jul; 38(4):240-50. PubMed ID: 18514080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical imaging of hypoxia: Current status and future directions.
    Bonnitcha P; Grieve S; Figtree G
    Free Radic Biol Med; 2018 Oct; 126():296-312. PubMed ID: 30130569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of and diagnostic methods for tumoral hypoxia].
    Maslennikova AV; Orlova AG; Prianikova TI; Kostenikov NA; Vinogradova IuN; Denisenko AN
    Vopr Onkol; 2011; 57(4):413-20. PubMed ID: 22191227
    [No Abstract]   [Full Text] [Related]  

  • 35.
    Qian Y; Von Eyben R; Liu Y; Chin FT; Miao Z; Apte S; Carter JN; Binkley MS; Pollom EL; Harris JP; Prionas ND; Kissel M; Simmons A; Diehn M; Shultz DB; Brown JM; Maxim PG; Koong AC; Graves EE; Loo BW
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1183-1192. PubMed ID: 29859786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single photon emission computed tomography and positron emission tomography in cancer imaging.
    Coleman RE
    Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging tumour hypoxia with oxygen-enhanced MRI and BOLD MRI.
    O'Connor JPB; Robinson SP; Waterton JC
    Br J Radiol; 2019 Mar; 92(1095):20180642. PubMed ID: 30272998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatment.
    Busk M; Horsman MR
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):219-34. PubMed ID: 24045619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Amino Acid-Based Radiopharmaceuticals for Tumor Imaging.
    Zhu J; Song X; Zhang J
    Mini Rev Med Chem; 2018; 18(7):561-583. PubMed ID: 27121713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Functional CT Contrast Agent for In Vivo Imaging of Tumor Hypoxia.
    Shi H; Wang Z; Huang C; Gu X; Jia T; Zhang A; Wu Z; Zhu L; Luo X; Zhao X; Jia N; Miao F
    Small; 2016 Aug; 12(29):3995-4006. PubMed ID: 27345304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.